This Event has now run. Thank you to our Speakers, Sponsors, and Delegates who joined us in London for the Summit!
The CAR-TCR Series: Your European Hub of Next Generation Cell Therapy Innovation
Cell therapy continues to transform the oncology field with advances across in vivo engineering and novel armouring enhancements. Despite investment challenges, innovation is not slowing for those working in CAR-TCR drug development.
Providing exclusive access to the most cutting-edge advances across pre-clinical platforms, clinical advances, and streamlined manufacturing, the 7th CAR-TCR Summit Europe was the must-attend forum to stay at the forefront of cell therapy innovations.
Cell therapy industry experts united in London in February 2024 at the only cell therapy conference looking in-depth at boosting clinical durability, advancing predictive biomarkers, and implementing safety switches through to automating production and accelerating analytical processes to reduce operational costs and turnaround times; and new cell therapy technology.
“The advancement of cell therapies to next generation and beyond will take substantial collaboration amongst the community. This cell therapy conference presents a great opportunity for companies and executives to connect on issues and opportunities alike and find common ground to move forward.”
Brian Kobel, Chief Executive Officer, TC Biopharm
What Was New for 2024?
Investor & Biopharma Partnerships Evening:
Gain insight into the decision making made by investors and network to create valuable connections to support future funding strategy
C-Level Think Tank:
An exclusive collaboration opportunity to discuss the industry’s most critical challenges
New Clinical Data From:
IRCCS Bambino Gesu Children’s Hospital, Immatics, Caribou Biosciences, Carisma Therapeutics, and Kyverna Therapeutics
2024 Expert Speakers Included:
President, Science & Technology
Chief Business Officer
Head of Technology & Innovation
“The 7th CAR-TCR Summit Europe provides a unique opportunity for leaders in the cell/gene therapy field to hear of all the advances made and importantly network with other leaders.”
David Fontata, Chief Business Officer & Chief Operating Officer, Umoja Biopharma
Who Attended in 2024:
"CAR-TCR London is a must in the calendar, a uniquely focused cell therapy conference to stay updated on the key trends and innovations in the development and manufacturing of these innovative and exciting therapies."
Lindsey Clarke, Co-Founder, The CGT Circle